Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportClinical Research/R&D Search Results « » The Henry J. Kaiser Family Foundation

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Improved, Modern Housing Can Help Reduce Malaria Risk, Study Says

Reuters: Modern housing could cut risk of malaria by up to half — study “Modernizing mud huts and other traditional housing could significantly cut the risk of malaria for people living in some of the highest risk areas of Africa, Asia, and South America, according to new research. Scientists who…

Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases Roger Bate, scholar at the American Enterprise Institute “…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance…

GHTC Blog Post Discusses Global Health R&D Outcomes From WHA Meeting

Global Health Technologies Coalition’s “Breakthroughs”: World Health Assembly roundup: News on global health research and innovation Ashley Bennett, GHTC’s global policy officer, discusses outcomes from the World Health Assembly, writing, “While we’re very excited by the progress made, much hinges on the connections between this year’s assembly decisions, the finalization…

Global Health Innovation Act Would Support Innovation In Global Health R&D

Global Health Technology Coalition’s “Breakthroughs”: New legislation would strengthen USAID’s role in global health R&D Courtney Carson, GHTC’s senior policy and advocacy associate, examines key provisions of the Global Health Innovation Act (H.R. 2241) and notes that the new legislation would direct “USAID to analyze how it is using innovation…

Blog Post Highlights Journal Article On Developing TB Treatments For Underserved Populations

Center for Global Health Policy’s “Science Speaks”: Children, people with HIV, pregnant women, and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say Antigone Barton, senior editor and writer of “Science Speaks,” discusses “an article [published] in a recently released Journal of Infectious…